HOME >> BIOLOGY >> NEWS
Cooperation to create a new tuberculosis vaccine

This release is also available in German

A cooperation agreement to initiate the development of a new type of preventive DNA subunit vaccine against tuberculosis (TB) has been signed by the Max Planck Institute for Infection Biology (MPI-IB) and MOLOGEN AG in Berlin. Subunit vaccines are composed of defined molecular immunogenic modules. Under its director Prof. Dr. Stefan H. E. Kaufmann, the Department of Immunology at the MPI-IB is studying the mechanisms of host - pathogen interactions and develops novel vaccination strategies; it is amongst the leading groups in Tuberculosis immunology research world wide. MOLOGEN focuses on proprietary DNA technologies to develop treatments for non- or inadequately treatable diseases.

With more than 2 million deaths and 9 million new infections annually, TB, along with malaria and HIV/AIDS, is responsible for the greatest number of infectious disease victims world wide. Of particular concern is the increasing number of pathogens resistant to conventional medication. The World Health Organisation estimates that some 50 million people around the globe are already infected with such multi-resistant strains. As the current TB vaccine BCG fails to protect against the most common form of the disease, pulmonary TB in adults, the need for an efficacious tuberculosis vaccine is more urgent than ever.

"The only prevention of TB is the viable BCG vaccine (Bacillus-Calmette-Guérin), which has been in use since 1921," says MPI-IB director Prof. Stefan H.E. Kaufmann. "BCG has a proven safety record for many decades, however, it unfortunately lacks effectiveness," notes Kaufmann, adding that only children can be protected against certain forms of TB by BCG. "however, BCG does not protect against pulmonary TB in adults at all. We assume the protection provided by BCG to be so limited because BCG bacteria fail to induce the compl
'"/>

Contact: Dr. Sabine Englich
englich@mpiib-berlin.mpg.de
49-302-846-0142
Max-Planck-Gesellschaft
8-Oct-2004


Page: 1 2 3

Related biology news :

1. 2006 AAAS International Scientific Cooperation Award goes to Arizona State U. landscape ecologist
2. Cooperation is keya new way of looking at MicroRNA and how it controls gene expression
3. Newly created cancer stem cells could aid breast cancer research
4. MIT creates 3-D images of living cell
5. Not all embryonic stem cell lines are created equal
6. Researchers use adult stem cells to create soft tissue
7. Fusing imaging technologies creates synergy, helps diagnose heart disease accurately
8. Researchers create model of cancer-preventing enzyme, study how it works
9. Researchers create interactive map with Google technology to track avian flu spread
10. Cancer scientists create human leukemia process to map how disease begins, progresses
11. Early-stage sperm cells created from human bone marrow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/6/2019)... , ... August 05, 2019 , ... Keck Graduate Institute ... School of Pharmacy and Health Sciences (SPHS). , “Dean Zdanowicz is highly regarded as ... Trustees Chairman Jim Widergren. “He is a great choice to build on the success ...
(Date:8/4/2019)... ... August 02, 2019 , ... Stay on top of ... device and food industries. Access to all webinars is free, so be sure to ... your field! , Visit http://www.xtalks.com to see our upcoming webinars: , CLINICAL ...
(Date:8/1/2019)... , ... August 01, 2019 , ... John R. Freeman, ... Fruehauf, MD, PhD, founder and president of BioLabs, which provides premier co-working spaces for ... role to strengthen our ability to forecast and manage growth,” says Fruehauf. “BioLabs has ...
Breaking Biology News(10 mins):
(Date:7/30/2019)... ... July 30, 2019 , ... The summer season has ... company. Not only has the company already hosted many of its signature cooking ... to its guests. , With Lajollacooks4u’s Private Cooking Parties, guests prepare and enjoy ...
(Date:7/19/2019)... ... July 18, 2019 , ... ... their investment to enlarge their current piezo motion facilities in Lederhose, Germany, increasing ... floors for multilayer piezo ceramic assembly production in addition to general office space, ...
(Date:7/17/2019)... , ... July 16, 2019 ... ... long-term strategic agreement for the development and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), ... this collaboration, AveXis, a Novartis company, will have dedicated manufacturing space at ...
(Date:7/9/2019)... ... July 08, 2019 , ... Today, at the ... National Corn Growers Association (NCGA) announced the winners of the Consider Corn ... product or process using field corn to produce biobased materials. , “Corn is a ...
Breaking Biology Technology:
Cached News: